Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity

The aim of this study was to investigate initiation of and persistence with warfarin treatment in patients with atrial fibrillation (AF) according to ethnicity. Patients hospitalized with first-time AF from 1997 to 2009, prescription claims of warfarin and country of birth were identified by individ...

Full description

Bibliographic Details
Main Authors:	Hansen, Carolina Malta, Olesen, Jonas Bjerring, Hansen, Morten Lock, Azimi, Aziza, Torp-Pedersen, Christian, Dominguez, Helena
Format:	Online
Language:	English
Published:	Frontiers Research Foundation 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385210/

Similar Items

Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study
by: Christiansen, Christine Benn, et al.
Published: (2013)

Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
by: Sørensen, Rikke, et al.
Published: (2013)

Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in Denmark
by: Staerk, Laila, et al.
Published: (2016)

Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study
by: Pallisgaard, Jannik Langtved, et al.
Published: (2015)

New-Onset Atrial Fibrillation Is a Predictor of Subsequent Hyperthyroidism: A Nationwide Cohort Study
by: Selmer, Christian, et al.
Published: (2013)

The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study
by: Selmer, Christian, et al.
Published: (2012)

Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study
by: Lindhardsen, Jesper, et al.
Published: (2012)

The use of warfarin in veterans with atrial fibrillation
by: Bravata, Dawn M, et al.
Published: (2004)

Risk of incident atrial fibrillation in patients presenting with retinal artery or vein occlusion: a nationwide cohort study
by: Christine Benn Christiansen, et al.
Published: (2018-05-01)

Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
by: Molteni, Mauro, et al.
Published: (2014)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-01-01)

Unexplained Syncope and Diagnostic Yield of Tests in Syncope According to the ICD-10 Discharge Diagnosis
by: Ruwald, Martin Huth, et al.
Published: (2013)

Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
by: Halvorsen, Sigrun, et al.
Published: (2014)

Treatment Persistence and Discontinuation with Rivaroxaban, Dabigatran, and Warfarin for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation in the United States
by: Coleman, Craig I., et al.
Published: (2016)

Profibrotic pathways and atrial cardiomyopathy in persistent atrial fibrillation
by: Canpolat, Uğur
Published: (2016)

The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden
by: Björholt, Ingela, et al.
Published: (2007)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
by: de Padua Mansur, Antonio, et al.
Published: (2012)

Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
by: Lee, Soyon, et al.
Published: (2012)

Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices
by: Ewen, Edward, et al.
Published: (2012)

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
by: Choi, Jiyoon C, et al.
Published: (2014)

Association of GGCX gene polymorphism with warfarin dose in atrial fibrillation population in Xinjiang
by: Kamali, Xiayizha, et al.
Published: (2013)

Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty
by: Juma, Salima, et al.
Published: (2013)

Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
by: Wisløff, Torbjørn, et al.
Published: (2014)

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2011-01-01)

The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation
by: Simon, Teresa A., et al.
Published: (2016)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
by: Benamer, Sufyan, et al.
Published: (2016)

International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
by: Nelson, Winnie W., et al.
Published: (2015)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
by: Touchette, Daniel R., et al.
Published: (2008)

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
by: Breithardt, Günter, et al.
Published: (2016)

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
by: Yao, Xiaoxi, et al.
Published: (2016)

Motion of left atrial appendage as a determinant of thrombus formation in patients with a low CHADS2 score receiving warfarin for persistent nonvalvular atrial fibrillation
by: Ono, Koji, et al.
Published: (2012)

Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study
by: Staerk, Laila, et al.
Published: (2015)

A clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation
by: LaHaye, Stephen Andrew, et al.
Published: (2012)

A Totally Thoracoscopic Ablation for Persistent Atrial Fibrillation
by: Choi, Sung Sil
Published: (2013)

ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2011-01-01)

Cryoablation in persistent atrial fibrillation – a critical appraisal
by: Tzeis, S., et al.
Published: (2016)

Sequential Hybrid Procedure for Persistent Atrial Fibrillation
by: Bulava, Alan, et al.
Published: (2015)

Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience
by: Abelson, Mark
Published: (2013)

Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
by: Michele Scarano, et al.
Published: (2017-04-01)

Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin
by: Reddy, Vivek Y., et al.
Published: (2016)